All articles tagged: Diarrhea, unspecified (R19.7)
HealthDay
09 July at 11.44 AM
Untreated Water Likely Source of Salmonella Outbreak Linked to CucumbersU.S. health officials have determined that untreated water used by a Florida cucumber grower is one likely source of salmonella poisoning that sickened nearly 450 people this spring.Still, that grower didn't supply all the cucumbers that were linked to salmonella contamination, the U.S. Food and Drug Administration noted in a recent <a |
HealthDay
17 June at 10.40 PM
CDC Warns of Salmonella Danger Posed by Pet Bearded DragonsIn a health advisory issued Friday, the U.S. Centers for Disease Control and Prevention warned of a Salmonella outbreak linked to pet bearded dragons, noting that there have been reports of 15 illnesses across nine states."Four people have been hospitalized," the agency said, although no deaths linked to the scaly pets have been reporte |
HealthDay
17 June at 03.58 PM
Survodutide Tied to Significant Improvement in Fatty Liver DiseaseMost patients taking survodutide, a dual agonist of glucagon receptor and glucagon-like peptide-1 (GLP-1) receptor, experience significant improvement in metabolic dysfunction-associated steatohepatitis (MASH) without worsening of fibrosis, according to a phase 2 study published online June 7 in the New England Journal of Medicine to |
Evalytics
19 March at 06.08 AM
FDA approves first drug for common form of liver inflammationThe FDA has approved the first-ever medication for nonalcoholic steatohepatitis (NASH), a common form of liver inflammation linked to obesity, type 2 diabetes, and other metabolic conditions. NASH, characterized by liver inflammation due to excess fat accumulation, affects an estimated 6 to 8 million people in the US with moderate to advanced fibrosis. |
Evalytics
26 February at 09.07 PM
Norovirus spreading in the Northeast, CDC data showsThe CDC warns of norovirus outbreak in the Northeastern U.S. Symptoms include vomiting, diarrhea, and stomach cramps. Health officials emphasize handwashing and disinfection to prevent spread. |
HealthDay
05 January at 04.32 PM
Atezolizumab Plus Standard Care Improves Survival in Advanced Cervical CancerFor patients with metastatic, persistent, or recurrent cervical cancer, adding atezolizumab to a standard bevacizumab plus platinum regimen significantly improves progression-free and overall survival, according to a study published in the January issue of The Lancet.Ana Oaknin, M.D., from the Vall d'Hebron Institute of Oncology in Barce |
HealthDay
05 January at 12.12 PM
Tejocote Supplements Sold Online at Amazon, Etsy May Contain Fatal Poison: FDATejocote weight-loss supplements sold online through Amazon or Etsy could contain a highly toxic substance, the U.S. Food and Drug Administration is warning.FDA tests revealed that capsules labeled as tejocote instead contained yellow oleander, a poisonous plant native to Mexico and Central America.The FDA found yellow oleander in nine dif |
HealthDay
22 December at 04.43 PM
FDA Warns of Counterfeit OzempicThe U.S. Food and Drug Administration has uncovered counterfeit Ozempic shots in the legitimate U.S. drug supply chain, and is warning patients to be on their guard.The FDA said Thursday that it has <a href="https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-consumers-not-use-counterfeit-ozempic-semaglutide-found-us-drug-supply-cha |
HealthDay
06 December at 10.55 PM
Eli Lilly Says Its New Weight-Loss Drug, Zepbound, Is Now AvailableEli Lilly has announced that its newly approved weight-loss medication, Zepbound, is now available for patients to take."Today opens another chapter for adults living with obesity who have been looking for a new treatment option like Zepbound," Rhonda Pacheco, group vice president of Lilly Diabetes and Obesity, U.S., said in a company news rel |
HealthDay
13 November at 11.56 PM
FDA Approves First Treatment for Congenital Thrombotic Thrombocytopenic PurpuraThe U.S. Food and Drug Administration has approved Adzynma, the first recombinant protein product indicated for prophylactic or on-demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP).Adzynma is a purified recombinant form of the ADAMTS13 enzyme that enhances the low l |
HealthDay
07 November at 11.50 PM
FDA Approves Voquezna for Erosive Esophagitis, GERDThe U.S. Food and Drug Administration has approved Voquezna (vonoprazan), a novel potassium-competitive acid blocker, as a new treatment for adults for with all grades of erosive esophagitis or erosive gastroesophageal reflux disease (GERD).The approval is based on the results of the PHALCON-EE phase 3 trial, in which Voquezna 20 mg met the prim |
Medpage Today
17 November at 10.31 PM
Two Treatments That Don't Work for OsteoarthritisWASHINGTON -- If you're looking for nonsurgical osteoarthritis (OA) treatments with fewer side effects than ordinary pain relievers, two randomized trials presented here with negative results should at least narrow your search... |
MedScape
11 November at 07.56 AM
Scoring System Could Mean Better Access to Lung TransplantScoring system could improve access for hard-to-match candidates due to height and blood type. |
Medical xPress
07 November at 07.50 AM
How key results could influence health policyThe results of some congressional races may foreshadow who will have outsize health policy influence in Congress next year. |
Medpage Today
05 November at 07.00 PM
Mpox Cases in Congo May Be StabilizingGOMA, Congo -- Some health officials say mpox cases in Congo appear to be "stabilizing" -- a possible sign that the main epidemic for which the World Health Organization (WHO) made a global emergency declaration in August... |
Medical xPress
02 November at 07.40 AM
Insulin resistance caused by sympathetic nervous system over-activation, a paradigm-shifting study findsRutgers Robert Wood Johnson Medical School and collaborating institutions have found that overnutrition leads to insulin resistance and metabolic disorders through increased activity of the sympathetic nervous system (SNS). The study shows that reducing SNS activity can prevent insulin resistance induced by a high-fat diet, suggesting a new understanding of how obesity causes insulin resistance. |
MedScape
31 October at 06.30 AM
Report: Rethink Race-Based Adjustments in Clinical ToolsThe slow adoption of race-neutral tools may harm patient care outcomes, according to a new report from the National Academies of Sciences, Engineering, and Medicine. |
Medpage Today
25 October at 02.09 PM
Patients More Satisfied With AI's Answers Than Those From Their DoctorPatients were consistently more satisfied with responses from artificial intelligence (AI) to messages in the electronic health record than they were with those from their clinician, according to a study in JAMA Network Open... |
Medical xPress
25 October at 12.40 PM
Surgical innovation: The intelligent turbine insufflatorThe Politecnico di Milano and the Erasmus Medical Center in Rotterdam have pooled their medical and technical expertise to create a new technology for devices called "insufflators." These innovative instruments are designed to create a temporary cavity in the bodies of patients through the application of pressurized gas, providing the surgeon with the necessary space to perform the surgical proced |
Medical xPress
24 October at 07.50 AM
Genetic variants in melatonin receptor linked to idiopathic osteoporosisColumbia University Medical Center researchers have identified specific variants in a melatonin receptor gene that impair bone turnover, leading to significant reductions in bone density and increased risk of fractures, particularly in Ashkenazi Jewish individuals. |
HealthDay
23 October at 10.58 PM
Risk for Psychiatric Disorders Up for Offspring of Moms With Eating DisorderOffspring of mothers with an eating disorder or prepregnancy body mass index (BMI) outside the normal weight range have an increased risk for psychiatric disorders, according to a study published online Oct. 22 in JAMA Network Open.Ida A.K. Nilsson, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues conducted a popula |